Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-λ, ε and ζ

被引:64
作者
Kampfer, S
Hellbert, K
Villunger, A
Doppler, W
Baier, G
Grunicke, HH
Überall, F [1 ]
机构
[1] Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Inst Med Biol, A-6020 Innsbruck, Austria
[3] Univ Innsbruck, Inst Human Genet, A-6020 Innsbruck, Austria
关键词
antisense RNA expression; c-fos; Ha-Ras; mitogenic signal transduction; protein kinase C isoenzymes;
D O I
10.1093/emboj/17.14.4046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The implication of protein kinase C (PKC) isoforms cPKG-alpha, nPKC-epsilon, aPKC-lambda and aPKC-zeta in the transcriptional activation of a c-fos promoter-driven CAT-reporter construct by transforming Ha-Ras has been investigated. This was achieved by employing antisense constructs encoding RNA directed against isoform-specific 5' sequences of the corresponding mRNA, and expression of PKC mutants representing either kinase-defective, dominant negative, or constitutively active forms of the PKC isoforms, The data indicate that in HC11 mouse mammary epithelial cells, transforming Ha-Ras requires the activities of the three PKC isozymes: aPKC-lambda, nPKC-epsilon and aPKC-zeta, not, however, of cPKC-alpha, for the transcriptional activation of c-fos. Co-expression of oncogenic Ha-Ras with combinations of kinase-defective, dominant negative and constitutively active mutants of the various PKC isozymes are in agreement with a tentative model suggesting that, in the signaling pathway from Ha-Ras to the c-fos promoter, aPKC-lambda acts upstream whereas aPKC-zeta functions downstream of nPKC-epsilon.
引用
收藏
页码:4046 / 4055
页数:10
相关论文
共 48 条
[1]  
AKIMOTO K, 1994, J BIOL CHEM, V269, P12677
[2]  
BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842
[3]  
BECKMAN BS, 1992, EXP HEMATOL, V20, P324
[4]   Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta [J].
Berra, E ;
DiazMeco, MT ;
Lozano, J ;
Frutos, S ;
Municio, MM ;
Sanchez, P ;
Sanz, L ;
Moscat, J .
EMBO JOURNAL, 1995, 14 (24) :6157-6163
[5]  
Bjorkoy G, 1997, J BIOL CHEM, V272, P11557
[7]  
Cacace AM, 1996, ONCOGENE, V13, P2517
[8]   Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase [J].
Cai, H ;
Smola, U ;
Wixler, V ;
EisenmannTappe, I ;
DiazMeco, MT ;
Moscat, J ;
Rapp, U ;
Cooper, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (02) :732-741
[9]   TRANSFORMATION BY RAS ONCOGENE INDUCES NUCLEAR SHIFT OF PROTEIN-KINASE-C [J].
CHIARUGI, V ;
MAGNELLI, L ;
PASQUALI, F ;
VANNUCCHI, S ;
BRUNI, P ;
QUATTRONE, A ;
BASI, G ;
CAPACCIOLI, S ;
RUGGIERO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (02) :528-533
[10]  
Dean N, 1996, CANCER RES, V56, P3499